Which are the causes of Hereditary multiple exostoses?

TL;DR: Hereditary multiple exostoses (HME) is a genetic condition caused by loss-of-function mutations in the EXT1 or EXT2 genes, which disrupts the body’s ability to regulate bone growth. Because these genes are inherited in an autosomal dominant pattern, an affected individual has a 50% chance of passing the condition to each of their children.

What causes Hereditary multiple exostoses?

Hereditary multiple exostoses is a skeletal disorder characterized by the development of multiple benign bone tumors, known as osteochondromas, near the growth plates of long bones. The primary cause of Hereditary multiple exostoses is a genetic mutation that impairs the synthesis of heparan sulfate, a complex sugar molecule essential for normal cellular signaling during bone development. Think of these genes as the "architects" of your bone growth; when the blueprints provided by EXT1 or EXT2 are faulty, the cells at the growth plate receive incorrect instructions, leading to the formation of these bony outgrowths rather than smooth, straight bone.

Is Hereditary multiple exostoses hereditary?

Yes, Hereditary multiple exostoses follows an autosomal dominant inheritance pattern. This means that if one parent carries the mutation, there is a 50% probability for each pregnancy that the child will inherit the disorder. While most cases are inherited, approximately 10% to 20% of cases occur as "de novo" or spontaneous mutations, meaning they appear in an individual with no prior family history of the condition. Genetic counseling is highly recommended for families navigating the inheritance of Hereditary multiple exostoses to better understand their specific risks.

What are the genetic factors involved?

Research has identified two primary genes responsible for the vast majority of Hereditary multiple exostoses cases:

• EXT1 gene: Mutations in this gene on chromosome 8 are the most common cause, accounting for roughly 60% to 70% of cases.


• EXT2 gene: Mutations in this gene on chromosome 11 account for approximately 20% to 30% of cases.


• Unknown mutations: In about 10% of patients, clinical testing does not reveal a mutation in either EXT1 or EXT2, suggesting that other, as-yet-undiscovered genes may contribute to the etiology of Hereditary multiple exostoses.

Are there environmental or external triggers?

Currently, there is no evidence to suggest that environmental factors, diet, or lifestyle choices trigger the onset of Hereditary multiple exostoses. Because the condition is fundamentally rooted in the genetic code present at conception, it is considered a developmental disorder rather than an autoimmune, infectious, or metabolic disease. While the physical impact of the exostoses can be affected by mechanical stress on the bones during growth, the underlying cause remains strictly genetic.

What is the current state of research?

Medical researchers are actively investigating how heparan sulfate deficiency alters the "hedgehog signaling pathway," a critical communication system that tells bone cells when to stop growing. Understanding this mechanism is the focus of current studies aimed at developing pharmacological interventions that could potentially slow or prevent the formation of new exostoses. With 266 members in the DiseaseMaps.org community living with Hereditary multiple exostoses, patient-led data collection is becoming increasingly valuable in helping researchers understand the natural history and clinical variability of the condition.

Next steps

• Consult with a clinical geneticist to confirm your specific mutation status.


• Schedule regular orthopedic monitoring, especially during childhood growth spurts, to track the size and location of exostoses.


• Connect with the 266 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Monitor clinical trial registries for upcoming research into bone growth modulation therapies.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hereditary multiple exostoses.


• Orphanet: Multiple osteochondromas (ORPHA:280).


• OMIM (Online Mendelian Inheritance in Man): Multiple Exostoses, Hereditary; EXT1/EXT2.


• The MHE Research Foundation: Resources for families and clinical updates.